WHO ICTRP trial
The Study of [68Ga]Ga-PD-L1 and [68Ga]Ga-CD8 PET/CT in Guiding Adaptive…
ChiCTR2500113309 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500113309 |
|---|---|
| Public title | The Study of [68Ga]Ga-PD-L1 and [68Ga]Ga-CD8 PET/CT in Guiding Adaptive Radioimmunotherapy for Locally Advanced Unresectable Non-Small Cell Lung Cancer |
| Scientific title | The Study of [68Ga]Ga-PD-L1 and [68Ga]Ga-CD8 PET/CT in Guiding Adaptive Radioimmunotherapy for Locally Advanced Unresectable Non-Small Cell Lung Cancer |
| Primary sponsor | Affiliated Cancer Hospital of Shandong First Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Patients with histologically confirmed driver gene wild-type non-small cell lung cancer (NSCLC) |
| Interventions | Observation Group of adaptive radiotherapy for non-small cell lung cancer:None |
| Registration date | Nov 27, 2025 |
| Target size | Observation Group of adaptive radiotherapy for non-small cell lung cancer:414 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: